275 related articles for article (PubMed ID: 21938566)
21. [Inhibition of curcumin on histone deacetylase and expression promotion of P21 (WAF1/CIP1) in HepG2 cells].
Lv BH; Zhang L; Zhu CC; Liu J
Zhongguo Zhong Yao Za Zhi; 2007 Oct; 32(19):2051-5. PubMed ID: 18161303
[TBL] [Abstract][Full Text] [Related]
22. Curcumin-mediated demethylation of the proximal promoter CpG island enhances the KLF4 recruitment that leads to increased expression of p21Cip1 in vitro.
Chatterjee B; Ghosh K; Kanade SR
J Cell Biochem; 2019 Jan; 120(1):809-820. PubMed ID: 30145810
[TBL] [Abstract][Full Text] [Related]
23. Curcumin Derivative Epigenetically Reactivates Nrf2 Antioxidative Stress Signaling in Mouse Prostate Cancer TRAMP C1 Cells.
Li W; Su ZY; Guo Y; Zhang C; Wu R; Gao L; Zheng X; Du ZY; Zhang K; Kong AN
Chem Res Toxicol; 2018 Feb; 31(2):88-96. PubMed ID: 29228771
[TBL] [Abstract][Full Text] [Related]
24. Epigenetic alterations differ in phenotypically distinct human neuroblastoma cell lines.
Yang Q; Tian Y; Ostler KR; Chlenski A; Guerrero LJ; Salwen HR; Godley LA; Cohn SL
BMC Cancer; 2010 Jun; 10():286. PubMed ID: 20546602
[TBL] [Abstract][Full Text] [Related]
25. Epigenetic regulation of metallothionein-i gene expression: differential regulation of methylated and unmethylated promoters by DNA methyltransferases and methyl CpG binding proteins.
Majumder S; Kutay H; Datta J; Summers D; Jacob ST; Ghoshal K
J Cell Biochem; 2006 Apr; 97(6):1300-16. PubMed ID: 16329111
[TBL] [Abstract][Full Text] [Related]
26. Research on the epigenetic regulation mechanism of the PTPN6 gene in advanced chronic myeloid leukaemia.
Zhang X; Yang L; Liu X; Nie Z; Wang X; Pan Y; Luo J
Br J Haematol; 2017 Sep; 178(5):728-738. PubMed ID: 28480959
[TBL] [Abstract][Full Text] [Related]
27. Epigenetic reactivation of RANK in glioblastoma cells by curcumin: involvement of STAT3 inhibition.
Wu B; Yao X; Nie X; Xu R
DNA Cell Biol; 2013 Jun; 32(6):292-7. PubMed ID: 23621850
[TBL] [Abstract][Full Text] [Related]
28. Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer.
Tada Y; Brena RM; Hackanson B; Morrison C; Otterson GA; Plass C
J Natl Cancer Inst; 2006 Mar; 98(6):396-406. PubMed ID: 16537832
[TBL] [Abstract][Full Text] [Related]
29. Histone deacetylase inhibitor depsipeptide activates silenced genes through decreasing both CpG and H3K9 methylation on the promoter.
Wu LP; Wang X; Li L; Zhao Y; Lu S; Yu Y; Zhou W; Liu X; Yang J; Zheng Z; Zhang H; Feng J; Yang Y; Wang H; Zhu WG
Mol Cell Biol; 2008 May; 28(10):3219-35. PubMed ID: 18332107
[TBL] [Abstract][Full Text] [Related]
30. Nrf2 expression is regulated by epigenetic mechanisms in prostate cancer of TRAMP mice.
Yu S; Khor TO; Cheung KL; Li W; Wu TY; Huang Y; Foster BA; Kan YW; Kong AN
PLoS One; 2010 Jan; 5(1):e8579. PubMed ID: 20062804
[TBL] [Abstract][Full Text] [Related]
31. Curcumin-induced histone hypoacetylation: the role of reactive oxygen species.
Kang J; Chen J; Shi Y; Jia J; Zhang Y
Biochem Pharmacol; 2005 Apr; 69(8):1205-13. PubMed ID: 15794941
[TBL] [Abstract][Full Text] [Related]
32. Promoter CpG island hypermethylation- and H3K9me3 and H3K27me3-mediated epigenetic silencing targets the deleted in colon cancer (DCC) gene in colorectal carcinogenesis without affecting neighboring genes on chromosomal region 18q21.
Derks S; Bosch LJ; Niessen HE; Moerkerk PT; van den Bosch SM; Carvalho B; Mongera S; Voncken JW; Meijer GA; de Bruïne AP; Herman JG; van Engeland M
Carcinogenesis; 2009 Jun; 30(6):1041-8. PubMed ID: 19329758
[TBL] [Abstract][Full Text] [Related]
33. Epigenetic repression of LEDGF during UVB exposure by recruitment of SUV39H1 and HDAC1 to the Sp1-responsive elements within LEDGF promoter CpG island.
Bhargavan B; Chhunchha B; Fatma N; Kubo E; Kumar A; Singh DP
Epigenetics; 2013 Mar; 8(3):268-80. PubMed ID: 23386123
[TBL] [Abstract][Full Text] [Related]
34. The reelin and GAD67 promoters are activated by epigenetic drugs that facilitate the disruption of local repressor complexes.
Kundakovic M; Chen Y; Guidotti A; Grayson DR
Mol Pharmacol; 2009 Feb; 75(2):342-54. PubMed ID: 19029285
[TBL] [Abstract][Full Text] [Related]
35. Epstein-barr virus latency in B cells leads to epigenetic repression and CpG methylation of the tumour suppressor gene Bim.
Paschos K; Smith P; Anderton E; Middeldorp JM; White RE; Allday MJ
PLoS Pathog; 2009 Jun; 5(6):e1000492. PubMed ID: 19557159
[TBL] [Abstract][Full Text] [Related]
36. Promoter demethylation and chromatin remodeling by green tea polyphenols leads to re-expression of GSTP1 in human prostate cancer cells.
Pandey M; Shukla S; Gupta S
Int J Cancer; 2010 Jun; 126(11):2520-33. PubMed ID: 19856314
[TBL] [Abstract][Full Text] [Related]
37. Promoter histone H3 lysine 9 di-methylation is associated with DNA methylation and aberrant expression of p16 in gastric cancer cells.
Meng CF; Zhu XJ; Peng G; Dai DQ
Oncol Rep; 2009 Nov; 22(5):1221-7. PubMed ID: 19787243
[TBL] [Abstract][Full Text] [Related]
38. Heterogeneous epigenetic regulation of TIMP3 in prostate cancer.
Shinojima T; Yu Q; Huang SK; Li M; Mizuno R; Liu ET; Hoon DS; Lessard L
Epigenetics; 2012 Nov; 7(11):1279-89. PubMed ID: 23023649
[TBL] [Abstract][Full Text] [Related]
39. Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer.
Cameron EE; Bachman KE; Myöhänen S; Herman JG; Baylin SB
Nat Genet; 1999 Jan; 21(1):103-7. PubMed ID: 9916800
[TBL] [Abstract][Full Text] [Related]
40. Identification of epigenetically silenced genes in tumor endothelial cells.
Hellebrekers DM; Melotte V; Viré E; Langenkamp E; Molema G; Fuks F; Herman JG; Van Criekinge W; Griffioen AW; van Engeland M
Cancer Res; 2007 May; 67(9):4138-48. PubMed ID: 17483324
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]